ImmunoPrecise Announces Data from Preclinical Study of TATX-03 PolyTope™ Monoclonal Antibody Cocktail Candidate Against COVID-19

Treatment of Syrian hamsters with a cocktail of four monoclonal antibodies resulted in strong anti-viral effects against SARS-CoV-2


IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares

H.C. Wainwright & Co. has purchased additional 242,443 shares of the Company at the public offering price of $13.45 per Additional Share.


IPA Announces Closing of $21.7 Million Bought Deal Offering of Common Shares
IPA has closed its public offering of 1,616,293 common shares of the Company.

IPA Increases Previously Announced Bought Deal Offering of Common Shares to $21.7 Million

The underwriter has agreed to increase the size of the previously announced public offering and purchase.


IPA Announces $10.0 Million Bought Deal Offering of Common Shares

IPA has entered into an underwriting agreement with H.C. Wainwright & Co., LLC.

Items 1 to 6 of 132 total

Show per page